<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04827238</url>
  </required_header>
  <id_info>
    <org_study_id>H21-00824</org_study_id>
    <nct_id>NCT04827238</nct_id>
  </id_info>
  <brief_title>Standardized Invasive Hemodynamics for Elevated Gradients Post TAVR</brief_title>
  <acronym>DISCORDANCE</acronym>
  <official_title>Standardized Invasive Hemodynamics for Monitoring Acute and Long Term Valve Performance in Patients With Elevated Gradients Post Transcatheter Aortic Valve Replacement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of British Columbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Edwards Lifesciences</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of British Columbia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The DISCORDANCE TAVR study will determine the discordance between echocardiography-derived&#xD;
      and invasive transaortic gradients, as determined by a consistent and reproducible technique&#xD;
      (Standardized Invasive Hemodynamics) post-TAVR.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 30, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Transaortic valve gradients</measure>
    <time_frame>30 days</time_frame>
    <description>Transaortic valve gradients measured by echocardiography and direct invasive methods</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Transaortic mean gradient reclassification</measure>
    <time_frame>30 days</time_frame>
    <description>Proportion of patients reclassified to a transaortic mean gradient &lt; 20mmHg using direct invasive methods</description>
  </primary_outcome>
  <primary_outcome>
    <measure>VARC-3 hemodynamic valve deterioration reclassification</measure>
    <time_frame>30 days</time_frame>
    <description>Proportion of patients reclassified to ≤ moderate VARC-3 hemodynamic valve deterioration using direct invasive methods, including mean gradient and valve area, compared to echocardiography</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient-Prosthesis Mismatch (PPM) reclassification</measure>
    <time_frame>30 days</time_frame>
    <description>Proportion of patients with echocardiographic severe PPM reclassified as non-severe PPM using direct invasive methods</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total procedure time</measure>
    <time_frame>30 days</time_frame>
    <description>Total procedure time (mins) to complete standardized invasive hemodynamics</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Aortic Stenosis</condition>
  <condition>Aortic Valve Stenosis</condition>
  <arm_group>
    <arm_group_label>Patients with Elevated Gradients Post Transcatheter Aortic Valve Replacement</arm_group_label>
    <description>Patients who have an echocardiographic transaortic mean gradient ≥ 20mmHg OR VARC-3 criteria for ≥ moderate hemodynamic valve deterioration post TAVR on any TTE &gt; 1 month post-TAVR</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Standardized Invasive Hemodynamics</intervention_name>
    <description>The SIH technique is a standardized, reproducible and efficient way of obtaining hemodynamic measurements.</description>
    <arm_group_label>Patients with Elevated Gradients Post Transcatheter Aortic Valve Replacement</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients &gt; 1 month post-transcatheter aortic valve replacement&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Echocardiographic transaortic mean gradient ≥ 20mmHg OR VARC-3 criteria for ≥ moderate&#xD;
             hemodynamic valve deterioration post TAVR on any TTE &gt; 1 month post-TAVR&#xD;
&#xD;
          -  Consensus by the Heart Team that the patient is suitable for Standardized Invasive&#xD;
             Hemodynamics (SIH).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  CT demonstrating leaflet thrombosis or hypoattenuated leaflet thickening (HALT)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>David Wood, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of British Columbia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nicole Carbert, MSc</last_name>
    <phone>604-838-1081</phone>
    <email>nicole.carbert@ubc.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>PIMA Heart Centre</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85712</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tom Waggoner, DO</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Emory University Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>George Hanzel, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Community Hospital</name>
      <address>
        <city>Munster</city>
        <state>Indiana</state>
        <zip>46321</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Samer Abbas, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sammy Elmmaria, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>William Beaumont Hospital</name>
      <address>
        <city>Southfield</city>
        <state>Michigan</state>
        <zip>48076</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Amr Abbas, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Morristown Medical Centre</name>
      <address>
        <city>Morristown</city>
        <state>New Jersey</state>
        <zip>07960</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Phillip Genereux, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Baylor Scott &amp; White</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75246</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Karim Al-Azizi, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vancouver General Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V5Z1M9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole Carbert, MSc</last_name>
      <phone>604-838-1081</phone>
      <email>nicole.carbert@ubc.ca</email>
    </contact>
    <investigator>
      <last_name>David A Wood, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Paul's Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6Z 1Y6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Grieve</last_name>
      <phone>604-682-2344</phone>
      <phone_ext>64980</phone_ext>
    </contact>
  </location>
  <location>
    <facility>
      <name>McMaster University</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8S 4L8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tej Sheth, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>March 29, 2021</study_first_submitted>
  <study_first_submitted_qc>March 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 1, 2021</study_first_posted>
  <last_update_submitted>September 28, 2021</last_update_submitted>
  <last_update_submitted_qc>September 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of British Columbia</investigator_affiliation>
    <investigator_full_name>David Wood</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

